Conference to Review Possible SGLT2 Inhibitor Side Effects
A leading professional organization devoted to the care and treatment of diabetes patients has announced a conference convened to review ketoacidosis as one of a handful of possible SGLT2 inhibitor side effects. The American Association of Clinical Endocrinologists (AACE) announced plans for the conference on June 29 after receiving questions... Read more »